Cite
HARVARD Citation
Atkinson, V. et al. (n.d.). 3337 Safety and effectiveness analysis of V600 BRAF-mutated metastatic melanoma (MM) patients (pts) from the dabrafenib (D) plus trametinib (T) named patient programme (NPP) - DESCRIBE II study. European journal of cancer. pp. S677-S678. [Online].